Prescription of Glucagon-Like Peptide 1 (GLP-1) in the treatment of patients with type 2 diabetes and obesity: a literature review. Acervo Médico [Internet]. 2022 Jun. 25 [cited 2026 Nov. 3];11:e10289. Available from: https://acervomais.com.br/medico/article/view/10289